The Ashley Treatment permanently altered the landscape of pediatric endocrinology and disability jurisprudence. It exposed a fundamental friction within medical ethics: the conflict between maximizing an individual's immediate physical comfort and defending universal protections over bodily integrity. While other families of children with profound neurodevelopmental conditions have sought growth attenuation therapy in subsequent years, medical centers navigate these requests under rigorous judicial scrutiny. The precedent established at Seattle Children's Hospital ensures that private clinical decisions regarding bodily modification cannot bypass independent judicial and public accountability.
Inside the Ashley Treatment: Medical Records and Procedures Revealed
•
•
10 min read
